Clinical validity assessment of genes for inclusion in multi-gene panel testing: A systematic approach.

Mol Genet Genomic Med 2019 05 21;7(5):e630. Epub 2019 Mar 21.

Ambry Genetics, Aliso Viejo, California.

Background: Advances in sequencing technology have led to expanded use of multi-gene panel tests (MGPTs) for clinical diagnostics. Well-designed MGPTs must balance increased detection of clinically significant findings while mitigating the increase in variants of uncertain significance (VUS). To maximize clinical utililty, design of such panels should include comprehensive gene vetting using a standardized clinical validity (CV) scoring system.

Methods: To assess the impact of CV-based gene vetting on MGPT results, data from MGPTs for cardiovascular indications were retrospectively analyzed. Using our CV scoring system, genes were categorized as having definitive, strong, moderate, or limited evidence. The rates of reported pathogenic or likely pathogenic variants and VUS were then determined for each CV category.

Results: Of 106 total genes, 42% had definitive, 17% had strong, 29% had moderate, and 12% had limited CV. The detection rate of variants classified as pathogenic or likely pathogenic was higher for genes with greater CV, while the VUS rate showed an inverse relationship with CV score. No pathogenic or likely pathogenic findings were observed in genes with a limited CV.

Conclusion: These results demonstrate the importance of a standardized, evidence-based vetting process to establish CV for genes on MGPTs. Using our proposed system may help to increase the detection rate while mitigating higher VUS rates.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503028PMC
May 2019

Publication Analysis

Top Keywords

pathogenic pathogenic
12
detection rate
8
gene vetting
8
multi-gene panel
8
clinical validity
8
genes
6
pathogenic
6
variants vus
4
limited evidence
4
pathogenic variants
4
evidence rates
4
vus determined
4
reported pathogenic
4
rates reported
4
determined categoryresults
4
definitive 17%
4
genes 42%
4
42% definitive
4
17% strong
4
total genes
4

Similar Publications